Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4f6ee64e420ffdad3e2fb360c93302a0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_95c89084d61fd47ae93470ca7c96f184 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-595 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-59 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-62 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1641 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-34 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-59 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-595 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-62 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1641 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-146 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-50 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-59 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-62 |
filingDate |
2006-10-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_198992cf678fe8f8287e81fe35ac02a6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5d81ea8c81ac5dc6438ecf3fe3630c9b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6f7c57dcde1000d6a5a9b1a46694e1aa http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b20177d47557c4117b0d1ca9d423f022 |
publicationDate |
2019-10-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
BR-PI0617775-B1 |
titleOfInvention |
particulate drug release system and its production process |
abstract |
Drug Delivery Systems The present invention relates to novel particulate drug delivery systems based on a polymeric support containing at least one linear, branched or crosslinked polymer in a fraction of more than 50 percent. by weight in relation to the total weight of the support. the system is characterized by the fact that at least one signal substance for transport through a biology barrier and at least one ingredient are stored, the carrier, the signal substance and the ingredient having no covalent bond and no ingredient-specific and signal-substance-specific coordinating linkages with one another. |
priorityDate |
2005-10-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |